First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
Catheter Cardiovasc Interv
; 88(6): 899-901, 2016 Nov 15.
Article
en En
| MEDLINE
| ID: mdl-27545489
ABSTRACT
Drug eluting stents are considered the "gold standard" for the percutaneous treatment of coronary artery disease. Recent publications have suggested that a reasonable alternative, in well selected cases, may be the ABSORBTM bioresorbable vascular scaffold (BVS) stent. © 2016 Wiley Periodicals, Inc.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Enfermedad de la Arteria Coronaria
/
Aprobación de Drogas
/
Vasos Coronarios
/
Implantes Absorbibles
/
Andamios del Tejido
/
Stents Liberadores de Fármacos
Tipo de estudio:
Diagnostic_studies
Límite:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Catheter Cardiovasc Interv
Asunto de la revista:
CARDIOLOGIA
Año:
2016
Tipo del documento:
Article